Sai Parenteral's Stellar Market Debut: Shares Surge Beyond Expectations

Sai Parenteral, a pharmaceutical company, saw its shares rise nearly 4% above the issue price on debut. With a fresh issue of Rs 285 crore and strong institutional backing, the IPO aims to bolster the firm's global business, particularly in formulations and manufacturing. Market valuation reached Rs 1,795.44 crore.

Sai Parenteral's shares delivered a notable performance on their debut, concluding nearly 4% above the issue price of Rs 392 on the stock exchange.

The pharmaceutical company's shares opened trading at Rs 405 on the BSE, rising 3.32% initially and peaking at Rs 416.20, before settling at Rs 406.40.

The IPO aims to raise Rs 285 crore for expanding its global formulations business, buoyed by a 1.05 times subscription rate and strong institutional interest.

(With inputs from agencies.)